ProfileGDS5678 / 1422435_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 15% 15% 15% 15% 15% 17% 16% 15% 15% 15% 15% 15% 15% 15% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.3921315
GSM967853U87-EV human glioblastoma xenograft - Control 22.372115
GSM967854U87-EV human glioblastoma xenograft - Control 32.3744915
GSM967855U87-EV human glioblastoma xenograft - Control 42.3176115
GSM967856U87-EV human glioblastoma xenograft - Control 52.328615
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.4712617
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.4219716
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.3478415
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.3367415
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.3594615
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.3563215
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.3422215
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.3723615
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.3640115